Evangelos Terpos

About Evangelos Terpos

Evangelos Terpos, With an exceptional h-index of 107 and a recent h-index of 72 (since 2020), a distinguished researcher at National and Kapodistrian University of Athens, specializes in the field of Myeloma, Thalassemia, Bone Disease, Hematology, SARS-CoV-2.

His recent articles reflect a diverse array of research interests and contributions to the field:

Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting

Thrombotic and bleeding complications in patients with AL amyloidosis

Retinopathy in a Patient With IgM MGUS: Causal Association or an Epiphenomenon?

INSURE: a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice

Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide‐exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA

Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic …

Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated …

Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin

Evangelos Terpos Information

University

Position

___

Citations(all)

53907

Citations(since 2020)

29073

Cited By

34811

hIndex(all)

107

hIndex(since 2020)

72

i10Index(all)

555

i10Index(since 2020)

409

Email

University Profile Page

National and Kapodistrian University of Athens

Google Scholar

View Google Scholar Profile

Evangelos Terpos Skills & Research Interests

Myeloma

Thalassemia

Bone Disease

Hematology

SARS-CoV-2

Top articles of Evangelos Terpos

Title

Journal

Author(s)

Publication Date

Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiveness and Safety of Ixazomib-based Therapy in Relapsed/Refractory Multiple Myeloma Outside of the Clinical Trial Setting

Clinical Lymphoma Myeloma and Leukemia

Heinz Ludwig

Karthik Ramasamy

María-Victoria Mateos

Bhuvan Kishore

Varga Gergely

...

2024/2/1

Thrombotic and bleeding complications in patients with AL amyloidosis

British Journal of Haematology

Despina Fotiou

Foteini Theodorakakou

Sotiria Spiliopoulou

Maria Gavriatopoulou

Magdalini Migkou

...

2024/2/6

Retinopathy in a Patient With IgM MGUS: Causal Association or an Epiphenomenon?

In Vivo

Ioannis Ntanasis-Stathopoulos

Efstathios Kastritis

John Tzartos

Evangelos Terpos

Meletios A Dimopoulos

...

2024/3/1

INSURE: a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice

Future Oncology

Xavier Leleu

Hans C Lee

Jeffrey A Zonder

Margaret Macro

Karthik Ramasamy

...

2024/5

Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide‐exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA

American Journal of Hematology

Evangelos Terpos

Ioannis Ntanasis‐Stathopoulos

Maria Gavriatopoulou

Eirini Katodritou

Evdoxia Hatjiharissi

...

2024/1/31

Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic …

Blood Cancer Journal

Ioannis V Kostopoulos

Despina Fotiou

Maria Gavriatopoulou

Pantelis Rousakis

Ioannis Ntanasis-Stathopoulos

...

2024/2/6

Belantamab mafodotin, lenalidomide, and dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma: Analysis of belantamab mafodotin-associated …

American journal of hematology

Maria Gavriatopoulou

Ioannis Ntanasis-Stathopoulos

Panagiotis Malandrakis

Despina Fotiou

Magdalini Migkou

...

2024/3

Early microvascular coronary endothelial dysfunction precedes pembrolizumab-induced cardiotoxicity. Preventive role of high dose of atorvastatin

Basic Research in Cardiology

Panagiotis Efentakis

Angeliki Choustoulaki

Grzegorz Kwiatkowski

Aimilia Varela

Ioannis V Kostopoulos

...

2024/3/23

High-Oxygen-Affinity Hemoglobins—Case Series and Review of the Literature

Veroniki Komninaka

Pagona Flevari

Evangelia-Eleni Ntelaki

Eleni Yfanti

Theodoros Androutsakos

...

2024/1/14

Circulating ferritin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis

Eleftheria Makri

Myrsini Orfanidou

Evangelia S Makri

Antonis Goulas

Evangelos Terpos

...

2024/2/2

Small RNA‐seq and clinical evaluation of tRNA‐derived fragments in multiple myeloma: Loss of mitochondrial i‐tRFHisGTG results in patients' poor treatment …

British Journal of Haematology

Konstantinos Soureas

Maria‐Alexandra Papadimitriou

Panagiotis Malandrakis

Aristea‐Maria Papanota

Panagiotis G Adamopoulos

...

2024/2/27

Characteristics and Outcomes of Patients With Relapsed/Refractory Multiple Myeloma After Exposure to Lenalidomide in First Line of Therapy: A Single Center Database Review in …

Leukemia & Lymphoma

Jiajia Liu

Douglas Stewart

Amelie Fontaine

Anthea Peters

Isabelle Fleury

...

2020/8/23

Implications and hidden toxicity of cardiometabolic syndrome and early‐stage heart failure in carfilzomib‐induced cardiotoxicity

British Journal of Pharmacology

Panagiotis Efentakis

Aimilia Varela

Sofia Lamprou

Eleni‐Dimitra Papanagnou

Michail Chatzistefanou

...

2024

Genetic justification of COVID‐19 patient outcomes using DERGA, a novel data ensemble refinement greedy algorithm

Journal of Cellular and Molecular Medicine

Panagiotis G Asteris

Amir H Gandomi

Danial J Armaghani

Markos Z Tsoukalas

Eleni Gavriilaki

...

2024/2

Low circulating tumor cell levels correlate with favorable outcomes and distinct biological features in multiple myeloma

Ioannis Kostopoulos

Ioannis Ntanasis-Stathopoulos

Pantelis Rousakis

Panagiotis Malandrakis

Chrysanthi Panteli

...

2024/2/26

Exploring the molecular biomarker utility of circCCT3 in multiple myeloma: A favorable prognostic indicator, particularly for R‐ISS II patients

HemaSphere

Maria Papatsirou

Christos K Kontos

Ioannis Ntanasis‐Stathopoulos

Panagiotis Malandrakis

Diamantis C Sideris

...

2024/1

Prognosis of COVID-19 severity using DERGA, a novel machine learning algorithm

European Journal of Internal Medicine

Panagiotis G Asteris

Amir H Gandomi

Danial J Armaghani

Styliani Kokoris

Anastasia T Papandreadi

...

2024/3/8

Single‐cell analysis of MYD88L265P and MYD88WT Waldenström macroglobulinemia patients

HemaSphere

Tina Bagratuni

Foteini Aktypi

Ourania Theologi

Maria Sakkou

Kleio Maria Verrou

...

2024/2

COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches

Sareh Kakavandi

Bahareh Hajikhani

Paniz Azizi

Fatemeh Aziziyan

Mohsen Nabi-Afjadi

...

2024/2/15

Long-term Survival in a Patient With Transformation of Waldenström’s Macroglobulinemia into DLBCL

Cancer Diagnosis & Prognosis

Eirini Solia

Ioannis Ntanasis-Stathopoulos

Efstathios Kastritis

Evangelos Terpos

Meletios A Dimopoulos

...

2024/1

See List of Professors in Evangelos Terpos University(National and Kapodistrian University of Athens)

Co-Authors

H-index: 164
Meletios Athanasios  Dimopoulos

Meletios Athanasios Dimopoulos

National and Kapodistrian University of Athens

H-index: 80
Kastritis Efstathios  OR Castritis Efstathios

Kastritis Efstathios OR Castritis Efstathios

National and Kapodistrian University of Athens

H-index: 62
THEODORA PSALTOPOULOU

THEODORA PSALTOPOULOU

National and Kapodistrian University of Athens

H-index: 51
GAVRIATOPOULOU MARIA

GAVRIATOPOULOU MARIA

National and Kapodistrian University of Athens

H-index: 48
Ioannis Trougakos

Ioannis Trougakos

National and Kapodistrian University of Athens

H-index: 48
Lia Angela Moulopoulos

Lia Angela Moulopoulos

National and Kapodistrian University of Athens

academic-engine